Inhibition of prostaglandin synthesis up-regulates cyclooxygenase-2 induced by lipopolysaccharide and peroxisomal proliferators

Journal of Pharmacology and Experimental Therapeutics

Volumn 288, Issue 3, 1999, Pages 1235-1241

  Callejas, Nuria A ^a   Castrillo, Antonio ^a   Boscá, Lisardo ^a   Martín Sanz, Paloma ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CLOFIBRATE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PEROXISOME PROLIFERATOR; PROSTAGLANDIN E2; PROSTAGLANDIN J2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME STABILITY; FEMALE; FETUS; LIVER CELL; LIVER MICROSOME; MALE; NEWBORN; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; RAT;

ANIMALS; CELLS, CULTURED; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; FEMALE; ISOENZYMES; LIPOPOLYSACCHARIDES; LIVER; PEROXISOME PROLIFERATORS; PROSTAGLANDIN ANTAGONISTS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; RATS; RATS, WISTAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; UP-REGULATION;

EID: 0033021515     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bamba H, Ota S, Kato A and Matsuzaki F (1998) Nonsteroidal anti-inflammatory drugs may delay the repair of gastric mucosa by suppressing prostaglandin-mediated increase of hepatocyte growth factor production. Biochem Biophys Res Commun 245:567-571.
2. Braissant O, Foufelle F, Scotto C, Dauca M and Wahli W (1996) Differential expression of peroxisome proliferator-activated receptors: Tissue distribution of PPARα, β, and γ in the adult rat. Endocrinology 137:354-366.
3. Casado M, Velasco M, Bosca L and Martín-Sanz P (1997) Absence of NO synthase type II expression in fetal liver from pregnant rats under septic shock conditions. Hepatology 25:1406-1411.
4. Chen ZY, Liu YF, He CY, White CC and Eaton DL (1994) Inhibition of cell proliferation by ciprofibrate in glutathione S-transferase P1-1-positive rat hepatic hyperplastic nodules Cancer Res 54:2622-2629.
5. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocianate-phenol-chloroform extraction. Anal Biochem 162:156-159.
6. Crofford LJ (1997) COX-1 and COX-2 tissue expression: Implications and predictions. J Rheumatol 24:15-19.
7. Dewitt DL (1991) Prostaglandin endoperoxide synthase: Regulation of enzyme expression. Biochim Biophys Acta 1083:121-134
8. Dowell P, Peterson VJ, Zabriskie TM and Leid M (1997) Ligand-induced peroxisome proliferator-activated receptor a conformational changes. J Biol Chem 272:2013-2020.
9. Feng L, Xia Y, Garcia GE, Hwang D and Wilson CB (1995) Involvement of reactive oxygen intermediates in cyclooxygenase-2 expression induced by interleukin-1, tumor necrosis factor-α, and lipopolysaccharide. J Clin Invest 95:1669-1675.
10. Fletcher BS, Kujubu DA, Perrin DM and Herschman HR (1992) Structure of the mitogen-inducible TIS10 gene and demonstration that the TIS10 encoded protein is a functional prostaglandin G/H synthase. J Biol Chem 267:4338-4344.
11. Green S (1995) PPAR: A mediator of peroxisome proliferator action. Mutat Res 333:101-109.
12. Herschman HR, Gilbert RS, Xie W, Luner S and Reddy ST (1995) The regulation and role of TIS10 prostaglandin synthase-2. Adv Prostaglandin Thromboxane Leukot Res 23:23-28.
13. Hinson RM, Williams JA and Shacter E (1996) Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: Possible role of cyclooxygenase-2. Proc Natl Acad Sci USA 93:4885-4890.
14. Isseman I and Green S (1990) Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (London) 347:645-649.
15. Johnston DE and Kroening C (1996) Stimulation of prostaglandin synthesis in cultured liver cells by CC14. Hepatology 24:677-684.
16. Kalgutkar AS, Crews BC, Rowlinson SW, Gamer C, Seibert K and Marnett LJ (1998) Aspirin-like molecules that covalently inactivate cyclooxygenase-2. Science (Wash DC) 280:1268-1270.
17. Keller H, Dreyer C, Medin J, Mahfoudi A, Ozato K and Wahli W (1993) Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc Natl Acad Sci USA 90:2160-2164.
18. Kliewer SA, Forman BM, Blumberg B, Ong ES, Borgmeyer U, Mangelsdorf DJ, Umesono K and Evans RM (1994) Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc Natl Acad Sci USA 91:7355-7359.
19. Krey G, Braissant O, L'Horset F, Kalhoven E, Perroud M, Parker MG and Wahli W (1997) Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferators activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol 11:779-791.
20. Kujubu DA, Fletcher BS, Varnun BC, Linn RW and Herschman HR (1991) TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266:12866-12872.
21. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 277:680-685.
22. Lee SS-T, Pineau T, Drago J, Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Wesphal H and Gonzalez FJ (1995) Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators. Mol Cell Biol 15:3012-3022.
23. Ledwith BJ, Pauley CJ, Wagner LK, Rokos CL, Alberts DW and Manam S (1997) Induction of cyclooxygenase-2 expression by peroxisome proliferators and non-tetradecanoylphorbol 12,13 myristate-type tumor promoters in immortalized mouse liver cells. J Biol Chem 272:3707-3714.
24. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM and Kliewer SA (1997) Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J Biol Chem 272: 3406-3410.
25. Martín-Sanz P, Cascales M and Bosca L (1989) Glucagon-induced changes in fructose 2,6-bisphosphate and 6-phosphofructo-2-kinase in cultured rat foetal hepatocytes. Biochem J 257:795-799.
26. Nanji AA, Miao L, Thomas P, Rahemtulla A, Khwaja S, Zhao S, Peters D, Tahan SR and Dannenberg AJ (1997) Enhanced cyclooxygenase-2 gene expression in alcoholic liver disease in the rat. Gastroenterology 112:943-951.
27. Pang L and Hoult JR (1996) Induction of cyclooxygenase and nitric oxide synthase in endotoxin-activated J774 macrophages is differentially regulated by indomethacin: enhanced cyclooxygenase-2 protein expression but reduction of inducible nitric oxide synthase. Eur J Pharmacol 317:151-155.
28. Pilbeam CC, Kaweaguchi H, Hakeda Y, Voznesensky O, Alander CB and Raisz LG (1993) Differential regulation of inducible and constitutive prostaglandin endoperoxide synthase in osteoblastic MC3T3-E1 cells. J Biol Chem 268:25643-25649.
29. Ryseck R-P, Raynoschek C, Macdonald-Bravo H, Dorfman K, Mattei M-G and Bravo R (1992) Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity. Cell Growth Differ 3:433-450.
30. Salvemini D, Settle SL, Masferrer JL, Seibert K, Currie MG and Needleman P (1995) Regulation of prostaglandin production by nitric oxide: An in vivo analysis. Br J Pharmacol 114:1171-1178.
31. Smith WL, Garavito RM and Dewitt DL (1996) Prostaglandin endoperoxidase H synthases (Cyclooxygenases)-1 and 2. J Biol Chem 271:33157-33160.
32. Williams CS and DuBois R (1996) Prostaglandin endoperoxide synthase: Why two isoforms. Am J Physiol 270:6393-6400.
33. Xie W, Chipman JG, Robertson DL and Erikson RL (1991) Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by RNA splicing. Proc Natl Acad Sci USA 88:2690-2696.
34. Yamada M, Niki H, Yamashita M, Mue S and Ohuchi K (1997) Prostaglandin E2 production dependent upon cyclooxygenase-1 and cyclooxygenase-2 and its contradictory modulation by auranofin in rat peritoneal macrophages. J Pharmacol Exp Ther 281:1005-1012.
35. Yu K, Bayona W, Kallen CB, Harding HP, Ravera CP, McMahon G, Brown M, Lazar MA (1995) Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J Biol Chem 270:23975-23983.
36. Yu M, Jamieson GA JR, Leikauf GD and Nebert DW (1998) Phospholipase A2 activation and increases in specific prostaglandins in the oxidatively stressed 14CoS/14CoS mouse hepatocyte line. Biochem Pharmacol 55:193-200.
37. Zhang F, Warskulat U, Wettstein M, Schreiber R, Henninger HP, Decker K and Haussinger D (1995) Hyperosmolarity stimulates prostaglandin synthesis and cyclooxygenase-2 expression in activated rat liver macrophages. Biochem J 312: 135-143.